4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-001732
Chair and CEO sold 38,635 shares at an average $70.18 ($2,711,456)
- Chair and CEO acquired 25,580 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lewis William · Chair and CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +18,750 | $22.76 | $426,750 | 411,339 | D |
| 2025-01-15 | Sale : show line 2 in the form 10b5-1 | −6,636 | $69.39 | $460,472 | 404,703 | D |
| 2025-01-15 | Sale : show line 3 in the form 10b5-1 | −22,696 | $70.32 | $1,595,983 | 382,007 | D |
| 2025-01-15 | Sale : show line 4 in the form 10b5-1 | −2,473 | $71.05 | $175,707 | 379,534 | D |
| 2025-01-15 | Exercise or conversion : show line 5 in the form 10b5-1 | +6,830 | $10.85 | $74,106 | 240,754 | I |
| 2025-01-15 | Sale : show line 6 in the form 10b5-1 | −1,499 | $69.40 | $104,031 | 239,255 | I |
| 2025-01-15 | Sale : show line 7 in the form 10b5-1 | −4,700 | $70.31 | $330,457 | 234,555 | I |
| 2025-01-15 | Sale : show line 8 in the form 10b5-1 | −631 | $71.01 | $44,807 | 233,924 | I |
| Open-market sales · 38,635 sh · avg $70.18 · $2,711,456 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-15 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) | −18,750 | 75,000 | D |
| 2025-01-15 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (right to buy) | −6,830 | 218,630 | I |
Loading xslF345X05/wk-form4_1737063445.xml…